Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidoglycan is a major, essential structural polymer forming the thick cell wall layer characteristic of Gram-positive bacteria, sometimes comprising up to 40 layers and up to 20% of the cell wall dry weight[1][6]. It is composed of alternating glycan chains of N-acetylglucosamine and N-acetylmuramic acid, cross-linked by peptide chains, forming a rigid lattice[1][2]. This structure provides mechanical strength, protects against osmotic lysis, helps maintain cell morphology, and serves as a scaffold for cell envelope components[1][6]. Peptidoglycan synthesis and cross-linking are the targets of widely used antibacterial drugs, including β-lactams and glycopeptides, making it one of the most important and validated antibacterial targets in infectious disease pharmacology[5][7]. Modifications to peptidoglycan structure contribute to antibiotic resistance mechanisms in clinically important pathogens. The peptidoglycan of Gram-positive bacteria is notably thicker than that in Gram-negative bacteria, lacking an outer membrane[1][2].
Inhibition of transpeptidation/cross-linking of peptidoglycan strands (β-lactams like penicillins, cephalosporins, carbapenems, monobactams); Inhibition of peptidoglycan polymerization (glycopeptides like vancomycin bind D-Ala-D-Ala, blocking cross-linking); Inhibition of cell wall precursor synthesis/transport (bacitracin, fosfomycin)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan of Gram-positive bacterial cell wall (null).